RHÖN-KLINIKUM Aktiengesellschaft (RKAGY)
- Previous Close
6.05 - Open
6.05 - Bid --
- Ask --
- Day's Range
6.05 - 6.05 - 52 Week Range
5.41 - 7.07 - Volume
1 - Avg. Volume
7 - Market Cap (intraday)
916.708M - Beta (5Y Monthly) -0.03
- PE Ratio (TTM)
19.52 - EPS (TTM)
0.31 - Earnings Date --
- Forward Dividend & Yield 0.08 (1.34%)
- Ex-Dividend Date Jun 8, 2023
- 1y Target Est
--
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.
www.rhoen-klinikum-ag.com10,017
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: RKAGY
Performance Overview: RKAGY
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RKAGY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RKAGY
Valuation Measures
Market Cap
916.71M
Enterprise Value
699.58M
Trailing P/E
19.49
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.52
Price/Book (mrq)
0.60
Enterprise Value/Revenue
0.48
Enterprise Value/EBITDA
5.98
Financial Highlights
Profitability and Income Statement
Profit Margin
2.23%
Return on Assets (ttm)
1.40%
Return on Equity (ttm)
3.17%
Revenue (ttm)
1.73B
Net Income Avi to Common (ttm)
38.71M
Diluted EPS (ttm)
0.31
Balance Sheet and Cash Flow
Total Cash (mrq)
342.84M
Total Debt/Equity (mrq)
11.70%
Levered Free Cash Flow (ttm)
22.36M
Company Insights: RKAGY
RKAGY does not have Company Insights